Jordi Parramon
Member Board of Directors @ Nexus NeuroTech Ventures
About
• Executive leader with 27+ years of relevant operational experience in Medical Devices and Health Tech at start-ups and large companies, combined with experience as an investor as a General Partner of a new capital firm focusing in companies devoted to solve Brain disorders.• Boards: Experienced board or board observer membership, including historically companies like Cala Heath, Insightec, Rune Labs, Lotus Neuro, EarliPoint, Galvani or Twenty Twenty therapeutics• Investor: founded Nexus Neurotech Ventures, build an investor team and a portfolio of 15 companies in 2.5 years.• Multi industry exposure: Experience with JV and pharma-tech partnerships when at Google (GSK, iRhythm, Sanofi, J&J, Alcon, Dexcom, P&G,..) allowed understanding at the intersection of Medical Devices, Pharma and Big Tech.• Product and Innovation: Led Engineering (Hardware, Software, AI/ML,..), Product Management and cross-functional teams (PMO, Manufacturing, Commercial,..) developing Class I through Class III Med Tech products. Authored/co-authored 150+ US patents.• Diverse experience in interventional and diagnostic fields: Neuromod/Bioelectronics (SCS/DBS/Autonomic), Diabetes (CGM, smart insulin pen and patch pumps), Ophthalmology (Retinal Imaging and Smart Contact Lens), Digital Surgery (AI/ML imaging, endoscopy, digital ecosystem), Cardiovascular (HF, aFib), Hearing aids, other bio-sensors and consumer health (Smart Watch, Skin Patch, Sleep tracking).
United States
San Francisco
Venture Capital & Private Equity
-
Experience
Board Member
Lotus Neuro
Member Board of Directors
Cala Health
San Francisco Bay Area
Board Observer
INSIGHTEC
Board Observer
EarliPoint Health
CEO, General Partner and Co-founder
Nexus NeuroTech Ventures
San Francisco Bay Area
Co-founded Nexus, a venture capital firm devoted to invest in companies improving with technology the lives of people with brain disorders. Over the course of 2.5 years Nexus Neurotech Ventures has build a portfolio of 15 highly innovative companies, usually leading or co-leading rounds ranging from $5M to $200M. Maturity of the companies spanned from seed stage all the way to cross-over rounds.
Member Board of Directors
Rune Labs
San Francisco, California, United States
Member Board Of Directors
Twenty/Twenty Therapeutics
United States
President, Medical Devices
Verily
South San Francisco, CA
Responsible to lead Verily's (an Alphabet-Google company) Medical Devices business, combining hardware, software and AI/ML to create differentiated clinically validated solutions for Verily's Clinical Research products (Study platform) and Health products (Retinal Screening Service, Onduo, Granular), as well as external Research and Commercial partnerships and Joint Ventures. Medical Devices specific revenue through 2017-2022 period of aprox $1.8B (including equity payments).
Head of Engineering, Hardware and Medical Devices
Verily
South San Francisco, CA
Responsible for all Hardware and Medical Devices engineering projects (10+ programs) and organization (200+ people) at Verily, with $100M+/year budget reporting to CEO.
Engineering Director, Medical Devices
Verily
South San Francisco, CA
Expanded Engineering to lead Medical Device projects with Sanofi on diabetes, Alcon on Smart contact lenses, J&J/Verb on Surgical visualization and Galvani on Bioelectronics. Reporting to CTO.
Engineering Director, Bioelectronics
Verily
South San Francisco, CA
Responsible to lead Verily partnership with GSK - Galvani on Bioelectronics. Reporting to CTO.
Member Board Of Directors
Galvani Bioelectronics
London, UK
Sr Director of R&D, Neuromodulation
Boston Scientific
Valencia, CA
Expanding Engineering Director to four functional areas: Hardware and Firmware systems, ASIC (Application Specific Integrated Circuits) and ATE (Automated Test Equipment). •Major product launches include Precision Spectra, Novi and Montage for Spinal Cord Stimulation (SCS) and Vercise-PC for Deep Brain Stimulation (DBS). Aprox $700M/year revenue. • Led cross-functional SCS WaveWriter program including investments in technology, Science/MOA and clinical evidence to bring novel Pain therapy to market. Main driver of global divisional YOY growth of aprox 20% once launched in 2018. • Active participant of IP board, strategic planning, Medical Advisory Board and significant NBD involvement.
Director of R&D, Implants Hardware and ASIC, Neuromodulation
Boston Scientific
Valencia, CA
• Engineering Director overseeing Integrated Circuit design plus Implant Electronics, focus on SCS Spectra –world’s first 32 contact Neuromod platform - including custom ASIC. Spectra had a $100M incremental revenue first year launch. • Technical talent development, IP portfolio, contributor to division strategic planning and technology roadmap
Manager of R&D, Integrated Circuit design
Boston Scientific
Valencia, CA
Manager and technical lead developing custom mixed-mode ASICs for Neuromod.
Education
Universitat Autònoma de Barcelona
Electrical Engineering
Universitat Autònoma de Barcelona
Electrical Engineering
Universitat Autònoma de Barcelona
Electrical Engineering
Universitat Autònoma de Barcelona
Physics
Jordi Parramon's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles
Find Emails
Access verified email addresses for your target contacts.
657M+ emails
Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers
More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.